{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-23",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 24
    }
  },
  "results": [
    {
      "discontinued_date": "10/20/2026",
      "update_type": "New",
      "initial_posting_date": "10/20/2026",
      "package_ndc": "0075-0624-30",
      "generic_name": "Enoxaparin Sodium Injection",
      "contact_info": "800-631-1610",
      "related_info": "Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.",
      "openfda": {
        "application_number": [
          "NDA020164"
        ],
        "brand_name": [
          "LOVENOX"
        ],
        "generic_name": [
          "ENOXAPARIN SODIUM"
        ],
        "manufacturer_name": [
          "Sanofi-Aventis U.S. LLC"
        ],
        "product_ndc": [
          "0075-0624",
          "0075-0620",
          "0075-0621",
          "0075-0622",
          "0075-0623",
          "0075-0626",
          "0075-2912",
          "0075-2915"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "ENOXAPARIN SODIUM"
        ],
        "rxcui": [
          "854228",
          "854232",
          "854235",
          "854236",
          "854238",
          "854239",
          "854241",
          "854242",
          "854245",
          "854247",
          "854248",
          "854249",
          "854252",
          "854253",
          "854255",
          "854256"
        ],
        "spl_id": [
          "cdb74d6d-1a74-4156-a52a-710c55cb2927"
        ],
        "spl_set_id": [
          "5017a927-2a24-4f27-89f9-27c805bf7d59"
        ],
        "package_ndc": [
          "0075-0624-01",
          "0075-0624-30",
          "0075-0620-01",
          "0075-0620-40",
          "0075-0621-01",
          "0075-0621-60",
          "0075-0622-01",
          "0075-0622-80",
          "0075-0623-03",
          "0075-0623-00",
          "0075-0626-03",
          "0075-2912-00",
          "0075-2912-01",
          "0075-2915-00",
          "0075-2915-01"
        ],
        "unii": [
          "8NZ41MIK1O"
        ]
      },
      "update_date": "10/20/2026",
      "therapeutic_category": [
        "Hematology"
      ],
      "dosage_form": "Injection",
      "presentation": "Lovenox, Injection, 30 mg/.3 mL (NDC 0075-0624-30)",
      "company_name": "Sanofi-Aventis U.S. LLC",
      "status": "To Be Discontinued"
    }
  ]
}